A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer

NCT01919749 ·Status: COMPLETED ·Phase: NA

Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls

NCT01312506 ·Status: WITHDRAWN

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

NCT02671045 ·Status: TERMINATED

Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer

NCT00898781 ·Status: TERMINATED

Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors

NCT02092714 ·Status: UNKNOWN

Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients

NCT04821895 ·Status: ACTIVE_NOT_RECRUITING

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

NCT02470819 ·Status: WITHDRAWN ·Phase: NA

Validation of MMS Test for Cancer Monitoring

NCT02113683 ·Status: TERMINATED

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

NCT00991991 ·Status: TERMINATED

Microbiome in Lung Cancer and Other Malignancies

NCT03688347 ·Status: COMPLETED

Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells

NCT01286883 ·Status: TERMINATED

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

NCT01031056 ·Status: WITHDRAWN

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

NCT01062438 ·Status: COMPLETED

Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery

NCT02566421 ·Status: TERMINATED ·Phase: NA

Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer

NCT02008994 ·Status: TERMINATED ·Phase: PHASE2

Genetic Characteristics of Metastatic Breast Cancer Patients

NCT04258735 ·Status: UNKNOWN ·Phase: NA

The Microbiome in Blood Cancer and HLH

NCT06734624 ·Status: NOT_YET_RECRUITING

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

NCT00899613 ·Status: UNKNOWN

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

NCT04431024 ·Status: RECRUITING

c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration

NCT05882292 ·Status: RECRUITING ·Phase: PHASE2

Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer

NCT05208372 ·Status: UNKNOWN

Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis

NCT03868215 ·Status: UNKNOWN

Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma

NCT06863870 ·Status: ACTIVE_NOT_RECRUITING

Genetic Testing for Men With Metastatic Prostate Cancer

NCT03503097 ·Status: TERMINATED

Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer

NCT04982224 ·Status: TERMINATED ·Phase: PHASE1